Login to Your Account



At this Year’s ASH, ‘Multiple Important Data Presentations’

By Anette Breindl
Science Editor

Monday, November 11, 2013

When the abstracts for the upcoming annual meeting of the American Society for Hematology were released last week, results of Geron Corp.’s Imetelstat were the biggest attention-grabber as far as the market was concerned. (See BioWorld Today, Nov. 8, 2013.)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription